CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Diverting ileostomy reversal complications in patients with benign versus malignant conditions

Author: 
Anestis Charalampopoulos, Efstratios Kofopoulos-Lymperis, George Bagias, George Kirkilesis, Marcos Perdicaris, Nikolaos Koliakos, Georgia Bobetsi, Savvas Papagrigoriadis and Dimitrios Papaconstantinou
Subject Area: 
Health Sciences
Abstract: 

Background: Reversal of ileostomy after surgery and chemoradiation creates a new group of patients with the potential for eventual postoperative complications. We aim to compare the postoperative morbidity of colorectal cancer patients with that of patients who underwent reversal of ileostomy for benign colorectal conditions. Methods: A retrospective analysis of patients undergoing ileostomy reversal was performed. Demographic, clinicopathologic features of patients, morbidity, initial diagnoses as well as rates of postoperative complications were analyzed. All complications after reversal of ileostomy were registered and classified according to Clavien-Dindo severity score. Results: 61 patients were divided in two groups; group A (21/61, 34.4%), included patients with benign colorectal diseases. The average time interval to reversal was 5.6±2.3 months and the in-hospital stay was 9.6±4.64 days. The overall complication rate was 33.3% (7/21) with wound infection rate at 14.3% (3/21). In group B (40/61, 65.6%), patients with malignancies maintained the ileostomy for an average of 8.2±3.3 months. In-hospital stay was 15.47±24 days and the overall complication rate was 65% (26/40). Wound infection was the most common complication with an incidence rate of 22.5%. The majority of complications in both groups was classified as Clavien-Dindo II and IIIa (14/61, 23%) while 9 patients (9/61,14.8%) had Clavien- Dindo score IIIb and IV. Conclusion: Reversal of ileostomy in cancer patients is correlated with a high complication rate. Wound infection and postoperative ileus were the most common complications. Cancer patients with reversal ileostomy had increased hospital in stay and delayed closure compared to patients with benign diseases.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran